58 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Five companies said to be in talks over $22 billion opioid settlement https://www.cnbc.com/2019/10/16/five-companies-said-to-be-in-talks-over-22-billion-opioid-settlement.html Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
TEVA: Gabelli & Co ups to Buy https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191017082319 Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
Teva settles Ohio opioid case for $45M in cash and Suboxone; shares up 17% https://seekingalpha.com/news/3507402-teva-settles-ohio-opioid-case-45m-cash-suboxone-shares-17-percent?source=feed_news_all Oct 21, 2019 - Teva Pharmaceutical Industries (TEVA +17.3%) has settled a lawsuit brought by two Ohio counties over its alleged role in the opioid epidemic there.Under the terms of the agreement, it has agreed to pa
J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos http://www.zacks.com/stock/news/575752/jj-jnj-recalls-baby-powder-batch-as-fda-finds-asbestos?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-575752 Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock? http://www.zacks.com/stock/news/583896/should-value-investors-buy-teva-pharmaceutical-industries-ltd-teva-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-583896 Oct 25, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/584773/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-584773 Oct 25, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $8.03, moving -1.65% from the previous trading session.
Teva Pharmaceutical Industries Limited (TEVA) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/07/teva-pharmaceutical-industries-limited-teva-q3-201.aspx?source=iedfolrf0000001 Nov 07, 2019 - TEVA earnings call for the period ending September 30, 2019.
Teva Pharmaceutical Industries Limited 2019 Q3 - Results - Earnings Call Presentation https://seekingalpha.com/article/4304322-teva-pharmaceutical-industries-limited-2019-q3-results-earnings-call-presentation?source=feed_tag_israel Nov 08, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q3 earnings call.
Why It Is Time To Load Up On Teva Stock https://seekingalpha.com/article/4305975-time-load-teva-stock?source=feed_tag_israel Nov 12, 2019 - Investors responded favorably to Teva's third-quarter earnings report.Litigation risks dissipating.Strong pipeline, initial sales of new drugs, and more.
Teva prices upsized $2.1B debt offering https://seekingalpha.com/news/3520567-teva-prices-upsized-2_1b-debt-offering?source=feed_news_all Nov 19, 2019 -

Pages: 123456

<Page 2>